Haemophilia

Cover image for Vol. 22 Issue 3

Early View (Online Version of Record published before inclusion in an issue)

Co-Editors C. Kessler and M. Makris

Impact Factor: 2.603

ISI Journal Citation Reports © Ranking: 2014: 33/68 (Hematology)

Online ISSN: 1365-2516

VIEW

  1. 1 - 54
  1. Letters to the Editor

    1. First trimester prenatal diagnosis of severe FXIII deficiency

      S. Shanbhag, K. Ghosh and S. Shetty

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12982

    2. Acquired haemophilia A in a Jehovah's Witness

      K. Chojnowski, M. Robak, W. Nowak and J. Treliński

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12992

  2. Original Articles

    1. Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies

      M. Napolitano, M. N. D. Di Minno, A. Batorova, A. Dolce, M. Giansily-Blaizot, J. Ingerslev, J.-F. Schved, G. Auerswald, G. Kenet, M. Karimi, T. Shamsi, A. Ruiz de Sáez, R. Dolatkhah, A. Chuansumrit, M. A. Bertrand and G. Mariani

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12978

    2. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland

      K. Vepsäläinen, R. Lassila, M. Arola, P. Huttunen, S. Koskinen, R. Ljung, P. Lähteenmäki, M. Möttönen and P. Riikonen

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12974

    3. You have full text access to this OnlineOpen article
      Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trial

      K. Saxena, S. Lalezari, J. Oldenburg, D. Tseneklidou-Stoeter, H. Beckmann, M. Yoon and M. Maas Enriquez

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12952

    4. Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin

      E. Santagostino, S. Pol, A. Olveira, H. W. Reesink, K. van Erpecum, P. Bogomolov, D. Xu, L. Critelli, S. Srinivasan and E. Cooney

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12947

    5. Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores

      J. Oldenburg, R. Zimmermann, O. Katsarou, E. Zanon, E. Kellermann, B. Lundin and P. Ellinghaus

      Version of Record online: 24 JUN 2016 | DOI: 10.1111/hae.12936

    6. You have full text access to this OnlineOpen article
      Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery

      C. Négrier, F. Abdul Karim, L. M. Lepatan, A. Lienhart, M. F. López-Fernández, J. Mahlangu, I. Pabinger, Y. Li, D. Wolko, C. Voigt, I. Jacobs and E. Santagostino

      Version of Record online: 22 JUN 2016 | DOI: 10.1111/hae.12972

  3. Letters to the Editor

    1. Rituximab as first-line therapy for acquired haemophilia A: a single-centre 10-year experience

      B. Rossi, P. Blanche, V. Roussel-Robert, A. Berezné, S. Combe, P. Coppo, L. Guillevin, C. Le Jeunne, L. Mouthon, N. Ounnoughene, N. Stieltjes and M. Groh

      Version of Record online: 22 JUN 2016 | DOI: 10.1111/hae.12973

  4. Original Articles

    1. You have full text access to this OnlineOpen article
      Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients

      B. Brand, R. Gruppo, T. T. Wynn, L. Griskevicius, M. F. Lopez Fernandez, M. Chapman, T. Dvorak, B. G. Pavlova and B. E. Abbuehl

      Version of Record online: 21 JUN 2016 | DOI: 10.1111/hae.12963

  5. Review Articles

    1. The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

      P. Collins, E. Chalmers, P. Chowdary, D. Keeling, M. Mathias, J. O'Donnell, K. J. Pasi, S. Rangarajan and A. Thomas

      Version of Record online: 16 JUN 2016 | DOI: 10.1111/hae.13013

  6. Original Articles

    1. Congenital macrothrombocytopenia is a heterogeneous disorder in India

      S. Ali, K. Ghosh, M. E. Daly, D. J. Hampshire, M. Makris, M. Ghosh, L. Mukherjee, M. Bhattacharya and S. Shetty

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12917

    2. Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European survey

      J. Windyga, G. Dolan, C. Altisent, O. Katsarou, M.-F. López Fernández, B. Zülfikar and on behalf of the EHTSB

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12955

  7. Review Articles

  8. Original Articles

    1. Identification of mutations in the F8 and F9 gene in families with haemophilia using targeted high-throughput sequencing

      C. Lyu, F. Xue, X. Liu, W. Liu, R. Fu, T. Sun, R. Wu, L. Zhang, H. Li, D. Zhang, R. Yang and L. Zhang

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12924

  9. Letters to the Editor

    1. Identification of von Willebrand disease type 1 in a patient with Ehlers–Danlos syndrome classic type

      H. W. Ott, S. Perkhofer, P. J. Coucke, A. de Paepe and M. Spannagl

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12931

  10. Original Articles

    1. Usefulness of the Total Thrombus-Formation Analysis System (T-TAS) in the diagnosis and characterization of von Willebrand disease

      V. Daidone, G. Barbon, M. G. Cattini, E. Pontara, C. Romualdi, I. Di Pasquale, K. Hosokawa and A. Casonato

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12971

  11. Letters to the Editor

    1. Interim results from a large multinational extension trial (guardian2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A

      S. R. Lentz, M. Cerqueira, D. Janic, C. Kempton, I. Matytsina, M. Misgav, J. Oldenburg, M. Ozelo, M. Recht, A. Rosholm, A. Savic, T. Suzuki, A. Tiede and E. Santagostino

      Version of Record online: 13 JUN 2016 | DOI: 10.1111/hae.12990

    2. Two new double mutant alleles of the F7 gene and a literature review on alleles with two mutations in FVII deficiency

      M. Giansily-Blaizot, N. Kolaitis, M. Borhany, G. Moulis, O. Guillot and T. Shamsi

      Version of Record online: 26 MAY 2016 | DOI: 10.1111/hae.12897

    3. Sodium content in products used to treat haemophilia

      C. Altisent, M. Martorell and A. de la Sierra

      Version of Record online: 26 MAY 2016 | DOI: 10.1111/hae.12948

    4. Defining adherence to prophylaxis in haemophilia

      L. H. Schrijvers, M. H. Cnossen, M. Beijlevelt-Van der Zande, M. Peters, M. J. Schuurmans and K. Fischer

      Version of Record online: 26 MAY 2016 | DOI: 10.1111/hae.12935

  12. Original Articles

    1. The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia

      S. von Mackensen, C. Harrington, E. Tuddenham, A. Littley, A. Will, M. Fareh, C. R. M. Hay and K. Khair

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/hae.12912

    2. Factor VIII assay variability in postinfusion samples containing full length and B-domain deleted FVIII

      S. Kitchen, I. Jennings, M. Makris, D. P. Kitchen, T. A. L. Woods and I. D. Walker

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/hae.12962

    3. Evidence of pathogenicity of a mutation in 3′ untranslated region causing mild haemophilia A

      B. Pezeshkpoor, A- C. Berkemeier, K. J. Czogalla, J. Oldenburg and O. El-Maarri

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/hae.12923

  13. Letters to the Editor

    1. Themes in daily life of adolescents and young adults with congenital bleeding disorders: a qualitative study

      P. Limperg, M. Peters, E. Gibbons, M. Coppens, C. Valk, M. Grootenhuis and L. Haverman

      Version of Record online: 24 MAY 2016 | DOI: 10.1111/hae.12961

  14. Original Articles

    1. Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents

      M. E. Mancuso, V. Chantarangkul, M. Clerici, M. R. Fasulo, L. Padovan, E. Scalambrino, F. Peyvandi, A. Tripodi and E. Santagostino

      Version of Record online: 16 MAY 2016 | DOI: 10.1111/hae.12939

  15. Letters to the Editor

    1. You have full text access to this OnlineOpen article
      Improving comprehensive care in the haemophilia community: building on the HERO Study

      A. Buzzi, L. Kelley, M. Gregory, M. Skinner and W. Kalnins

      Version of Record online: 11 MAY 2016 | DOI: 10.1111/hae.12945

  16. Original Articles

    1. The thrombin generation assay distinguishes inhibitor from non-inhibitor patients with severe haemophilia A

      M. E. Mancuso, V. Chantarangkul, M. Clerici, M. R. Fasulo, L. Padovan, E. Scalambrino, F. Peyvandi, A. Tripodi and E. Santagostino

      Version of Record online: 11 MAY 2016 | DOI: 10.1111/hae.12927

  17. Letters to the Editor

  18. Review Articles

  19. Original Articles

    1. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates

      N. K. Jha, S. A. Shestopal, M. J. Gourley, S. A. Woodle, Y. Liang, A. G. Sarafanov, M. Weinstein and M. V. Ovanesov

      Version of Record online: 1 APR 2016 | DOI: 10.1111/hae.12943

    2. Declining trends in invasive orthopedic interventions for people with hemophilia enrolled in the Universal Data Collection program (2000–2010)

      P. Tobase, H. Lane, A.-E-A. Siddiqi, R. Ingram-Rich, R. S. Ward and Universal Data Collection Joint Outcome Working Group, Hemophilia Treatment Center Network (HTCN) Study Investigators

      Version of Record online: 31 MAR 2016 | DOI: 10.1111/hae.12932

    3. Correlation between FIX genotype and pharmacokinetics of Nonacog alpha according to a multicentre Italian study

      M. Morfini, A. Dragani, E. Paladino, P. Radossi, G. Di Minno, M. G. Mazzucconi, G. Rossetti, G. Barillari, M. Napolitano and G. Tagariello

      Version of Record online: 14 MAR 2016 | DOI: 10.1111/hae.12916

    4. Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

      C. Negrier, G. Young, F. Abdul Karim, P. W. Collins, H. Hanabusa, T. Colberg, B. Goldman, C. E. Walsh and for the paradigm™ 2 and 4 Investigators

      Version of Record online: 3 MAR 2016 | DOI: 10.1111/hae.12902

    5. Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs

      K. E. Sherman, R. Ke, S. D. Rouster, E. A. Abdel-Hameed, C. Park, J. Palascak and A. S. Perelson

      Version of Record online: 3 MAR 2016 | DOI: 10.1111/hae.12918

    6. You have full text access to this OnlineOpen article
      Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis

      L. A. Valentino, S. W. Pipe, P. W. Collins, V. S. Blanchette, E. Berntorp, K. Fischer, B. M. Ewenstein, M. Oh and G. Spotts

      Version of Record online: 1 MAR 2016 | DOI: 10.1111/hae.12905

    7. Characterization of five associations of F8 missense mutations containing FVIII B domain mutations

      Y. Jourdy, C. Nougier, O. Roualdes, M. Fretigny, B. Durand, C. Negrier and C. Vinciguerra

      Version of Record online: 25 FEB 2016 | DOI: 10.1111/hae.12906

    8. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders

      J. M. Bastida, M. del Rey, M. L. Lozano, M. E. Sarasquete, R. Benito, M. E. Fontecha, R. Fisac, L. J. García-Frade, C. Aguilar, M. P. Martínez, E. Pardal, C. Aguilera, B. Pérez, R. Ramos, M. R. Cardesa, J. M. Martin-Antorán, L. A. Silvestre, M. J. Cebeira, N. Bermejo, S. Riesco, M. C. Mendoza, R. García-Sanz, M. González-Díaz, J. M. Hernández-Rivas and J. R. González-Porras

      Version of Record online: 15 FEB 2016 | DOI: 10.1111/hae.12908

    9. You have full text access to this OnlineOpen article
      Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA® in prophylactic therapy

      K. Varadi, S. Tangada, M. Loeschberger, P. Montsch, G. Schrenk, B. Ewenstein and P. L. Turecek

      Version of Record online: 15 FEB 2016 | DOI: 10.1111/hae.12873

    10. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease

      S. M. Siboni, E. Biguzzi, V. Caiani, C. Mistretta, P. Bucciarelli and F. Peyvandi

      Version of Record online: 4 FEB 2016 | DOI: 10.1111/hae.12900

VIEW

  1. 1 - 54

SEARCH

SEARCH BY CITATION